secwatch.observer — SEC 8-K summary
======================================

Issuer:     Jazz Pharmaceuticals plc (JAZZ)
CIK:        0001232524
Form:       8-K
Filed at:   2024-09-06T23:59:59+00:00
Accession:  0001193125-24-215168
Event type: debt
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 2.03, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Jazz Prices $1B 3.125% Exchangeable Notes Due 2030, Preps $500M Loan Repayment & $150M Buyback
--------------------------------------------------------------------------------

- $1.0B aggregate principal of 3.125% exchangeable senior notes due 2030, including $150M overallotment exercised.
- Initial exchange price ~$153.05 per share, a ~40% premium over Sept 3 closing price of $109.32.
- Net proceeds ~$981M; ~$500M to prepay term loans under credit agreement, remainder for general corporate.
- Concurrent $150M share repurchase from note purchasers at $109.32/share, reducing remaining buyback authority.
- Transaction closed Sept 6, 2024; notes guaranteed by Jazz on senior unsecured basis.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1232524/000119312524215168/0001193125-24-215168-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1232524/000119312524215168/d875709d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-215168

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer